These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 27357355)

  • 1. Circulating microRNAs strongly predict cardiovascular death in patients with coronary artery disease-results from the large AtheroGene study.
    Karakas M; Schulte C; Appelbaum S; Ojeda F; Lackner KJ; Münzel T; Schnabel RB; Blankenberg S; Zeller T
    Eur Heart J; 2017 Feb; 38(7):516-523. PubMed ID: 27357355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating MicroRNA-423-3p Improves the Prediction of Coronary Artery Disease in a General Population　- Six-Year Follow-up Results From the China-Cardiovascular Disease Study.
    Wang X; Dong Y; Fang T; Wang X; Chen L; Zheng C; Kang Y; Jiang L; You X; Gai S; Wang Z; Cao H
    Circ J; 2020 Jun; 84(7):1155-1162. PubMed ID: 32404537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miRNA-197 and miRNA-223 Predict Cardiovascular Death in a Cohort of Patients with Symptomatic Coronary Artery Disease.
    Schulte C; Molz S; Appelbaum S; Karakas M; Ojeda F; Lau DM; Hartmann T; Lackner KJ; Westermann D; Schnabel RB; Blankenberg S; Zeller T
    PLoS One; 2015; 10(12):e0145930. PubMed ID: 26720041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum microRNAs are key predictors of long-term heart failure and cardiovascular death after myocardial infarction.
    Rincón LM; Rodríguez-Serrano M; Conde E; Lanza VF; Sanmartín M; González-Portilla P; Paz-García M; Del Rey JM; Menacho M; García Bermejo ML; Zamorano JL
    ESC Heart Fail; 2022 Oct; 9(5):3367-3379. PubMed ID: 35837763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic Performance of Circulating miRNAs and Extracellular Vesicles in Acute Ischemic Stroke.
    Eyileten C; Jakubik D; Shahzadi A; Gasecka A; van der Pol E; De Rosa S; Siwik D; Gajewska M; Mirowska-Guzel D; Kurkowska-Jastrzebska I; Czlonkowska A; Postula M
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of miR-26a-5p and miR-19a-3p expression levels in angiographically confirmed coronary artery disease.
    Coban N; Erkan AF; Ozuynuk-Ertugrul AS; Ekici B
    Acta Cardiol; 2023 Oct; 78(8):945-956. PubMed ID: 37376990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review of microRNA biomarkers in acute coronary syndrome and stable coronary artery disease.
    Kaur A; Mackin ST; Schlosser K; Wong FL; Elharram M; Delles C; Stewart DJ; Dayan N; Landry T; Pilote L
    Cardiovasc Res; 2020 May; 116(6):1113-1124. PubMed ID: 31782762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating Extracellular miRNA Analysis in Patients with Stable CAD and Acute Coronary Syndromes.
    Zhelankin AV; Stonogina DA; Vasiliev SV; Babalyan KA; Sharova EI; Doludin YV; Shchekochikhin DY; Generozov EV; Akselrod AS
    Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34209965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-941 as a promising biomarker for acute coronary syndrome.
    Bai R; Yang Q; Xi R; Li L; Shi D; Chen K
    BMC Cardiovasc Disord; 2017 Aug; 17(1):227. PubMed ID: 28830367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating microRNAs as biomarkers for severe coronary artery disease.
    Zhang X; Cai H; Zhu M; Qian Y; Lin S; Li X
    Medicine (Baltimore); 2020 Apr; 99(17):e19971. PubMed ID: 32332683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profiling and validation of circulating microRNAs for cardiovascular events in patients presenting with ST-segment elevation myocardial infarction.
    Jakob P; Kacprowski T; Briand-Schumacher S; Heg D; Klingenberg R; Stähli BE; Jaguszewski M; Rodondi N; Nanchen D; Räber L; Vogt P; Mach F; Windecker S; Völker U; Matter CM; Lüscher TF; Landmesser U
    Eur Heart J; 2017 Feb; 38(7):511-515. PubMed ID: 28011706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating microRNA expression profiling and bioinformatics analysis of dysregulated microRNAs of patients with coronary artery disease.
    Zhong Z; Hou J; Zhang Q; Zhong W; Li B; Li C; Liu Z; Yang M; Zhao P
    Medicine (Baltimore); 2018 Jul; 97(27):e11428. PubMed ID: 29979444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating Exosomal miRNAs as Novel Biomarkers for Stable Coronary Artery Disease.
    Zhang P; Liang T; Chen Y; Wang X; Wu T; Xie Z; Luo J; Yu Y; Yu H
    Biomed Res Int; 2020; 2020():3593962. PubMed ID: 33381550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the associations between circulating microRNAs and kidney function in coronary angiography patients.
    Muendlein A; Geiger K; Leiherer A; Saely CH; Fraunberger P; Drexel H
    Am J Physiol Renal Physiol; 2020 Feb; 318(2):F315-F321. PubMed ID: 31813253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of circulating miRNAs during myocardial infarction and association with lipid levels.
    Ozuynuk-Ertugrul AS; Ekici B; Erkan AF; Coban N
    Lab Med; 2024 May; 55(3):361-372. PubMed ID: 38048807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating MicroRNAs as Novel Diagnostic Biomarkers for Very Early-onset (≤40 years) Coronary Artery Disease.
    DU Y; Yang SH; Li S; Cui CJ; Zhang Y; Zhu CG; Guo YL; Wu NQ; Gao Y; Sun J; Dong Q; Liu G; Li JJ
    Biomed Environ Sci; 2016 Aug; 29(8):545-554. PubMed ID: 27660218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating microRNAs as potential biomarkers for coronary plaque rupture.
    Li S; Lee C; Song J; Lu C; Liu J; Cui Y; Liang H; Cao C; Zhang F; Chen H
    Oncotarget; 2017 Jul; 8(29):48145-48156. PubMed ID: 28624816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-423 is differentially expressed in patients with stable and unstable coronary artery disease: A pilot study.
    Rizzacasa B; Morini E; Mango R; Vancheri C; Budassi S; Massaro G; Maletta S; Macrini M; D'Annibale S; Romeo F; Novelli G; Amati F
    PLoS One; 2019; 14(5):e0216363. PubMed ID: 31059534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a six-miRNA panel in serum benefiting pancreatic cancer diagnosis.
    Zou X; Wei J; Huang Z; Zhou X; Lu Z; Zhu W; Miao Y
    Cancer Med; 2019 Jun; 8(6):2810-2822. PubMed ID: 31006985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating miR-19b-3p as a Novel Prognostic Biomarker for Acute Heart Failure.
    Su Y; Sun Y; Tang Y; Li H; Wang X; Pan X; Liu W; Zhang X; Zhang F; Xu Y; Yan C; Ong SB; Xu D
    J Am Heart Assoc; 2021 Oct; 10(20):e022304. PubMed ID: 34612058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.